Tu Dan, M.D.

Assistant Professor

School: Medical School
Department: Radiation Oncology

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

Education

Medical School: University of Florida College of Medicine (2011)
Internship: University of Florida College of Medicine (2012), Internal Medicine
Residency: Sidney Kimmel Medical College at Thomas Jefferson University (2016), Radiation Oncology

Research Interest

mechanisms of post-transcriptional regulation of gene expression

Publications

Comparative Outcomes of Standard Radiation Therapy and 5-Fraction Adaptive Stereotactic Radiation Therapy in Newly Diagnosed Glioblastoma: A Propensity Score–Matched Analysis: Dohopolski M, Schmitt LG, De Vis JB, Mostardeiro TR, Anand S, Youssef M, Noch E, Maher EA, Sun M, Patel TR, Patel AR, Barnett SL, Lee M, Iakovenko V, Chiu T, Su FC, Pompos A, Lin M, Cai X, Timmerman R, Dan T, Wardak Z Advances in Radiation Oncology 2025 Aug 10
Exploratory Evaluation of Personalized Ultrafractionated Stereotactic Adaptive Radiation Therapy (PULSAR) With Central Nervous System-Active Drugs in Brain Metastases Treatment: Dohopolski M, Schmitt LG, Anand S, Zhang H, Stojadinovic S, Youssef M, Shaikh N, Patel T, Patel A, Barnett S, Lee DS, Ahn C, Lee MJ, Timmerman R, Peng H, Cai X, Dan T, Wardak Z International Journal of Radiation Oncology Biology Physics 2025 Jul 122 611-620
Standard Dose Versus Reduced Dose Single Fraction Preoperative Radiosurgery for Resected Brain Metastases (PROPS-BM) International Multicenter Cohort Study: Prabhu RS, Russek R, Vaslow ZK, Matsui JK, Haghighi N, Dan T, Mishra MV, Murphy ES, Boyles S, Perlow HK, Palmer JD, Udovicich C, Patel TR, Wardak Z, Woodworth GF, Ksendzovsky A, Yang K, Chao ST, Asher AL, Burri SH Advances in Radiation Oncology 2025 Jul 10
An ultraconserved snoRNA-like element in long noncoding RNA CRNDE promotes ribosome biogenesis and cell proliferation: Lee JS, Dan T, Zhang H, Cheng Y, Rehfeld F, Brugarolas J, Mendell JT Molecular cell 2025 Apr 85 1543-1560.e10
Multiomics-Based Outcome Prediction in Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy (PULSAR): Zhang H, Dohopolski M, Stojadinovic S, Schmitt LG, Anand S, Kim H, Pompos A, Godley A, Jiang S, Dan T, Wardak Z, Timmerman R, Peng H Cancers 2024 Oct 16
Where Does Auto-Segmentation for Brain Metastases Radiosurgery Stand Today?: Kim M, Wang JY, Lu W, Jiang H, Stojadinovic S, Wardak Z, Dan T, Timmerman R, Wang L, Chuang C, Szalkowski G, Liu L, Pollom E, Rahimy E, Soltys S, Chen M, Gu X Bioengineering 2024 May 11
BIOGUIDE-X: A First-in-Human Study of the Performance of Positron Emission Tomography-Guided Radiation Therapy: Vitzthum LK, Surucu M, Gensheimer MF, Kovalchuk N, Han B, Pham D, Chang D, Shirvani SM, Aksoy D, Maniyedath A, Narayanan M, Da Silva AJ, Mazin S, Feghali KA, Iyengar P, Dan T, Pompos A, Timmerman R, Öz O, Cai B, Garant A International Journal of Radiation Oncology Biology Physics 2024 Apr 118 1172-1180
Single-Fraction Versus Fractionated Preoperative Radiosurgery for Resected Brain Metastases: A PROPS-BM International Multicenter Cohort Study: Prabhu RS, Akinyelu T, Vaslow ZK, Matsui JK, Haghighi N, Dan T, Mishra MV, Murphy ES, Boyles S, Perlow HK, Palmer JD, Udovicich C, Patel TR, Wardak Z, Woodworth GF, Ksendzovsky A, Yang K, Chao ST, Asher AL, Burri SH International Journal of Radiation Oncology Biology Physics 2024 Mar 118 650-661
Modeling gamma knife radiosurgical toxicity for multiple brain metastases: Hsu EJ, Yan Y, Timmerman RD, Wardak Z, Dan TD, Patel TR, Vo D, Stojadinovic S Radiotherapy and Oncology 2023 Nov 188
Risk Factors for Progression and Toxic Effects after Preoperative Stereotactic Radiosurgery for Patients with Resected Brain Metastases: Prabhu RS, Akinyelu T, Vaslow ZK, Matsui JK, Haghighi N, Dan T, Mishra MV, Murphy ES, Boyles S, Perlow HK, Palmer JD, Udovicich C, Patel TR, Wardak Z, Woodworth GF, Ksendzovsky A, Yang K, Chao ST, Asher AL, Burri SH JAMA Oncology 2023 Aug 9 1066-1073